Journals / Sağlık ve Toplum / 2020 / Cilt: 30 - Sayı: 0

Some Matters to be Protected and Considered by Risk Groups From COVID-19 in the Context of Cancer Patients

Kanser Hastaları Bağlamında Risk Gruplarının COVID-19’dan Korunması ve Dikkate Alınması Gereken Bazı Hususlar

Pages
98–102
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is essential to provide sustainable health services for the disadvantaged groups at risk with the health for all approach and the slogan “no one left behind”.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The COVID-19 pandemic once again reminded health inequalities.
📊
Key Findings & Data:In addition to protecting patients at risk from COVID-19, it is the duty of the states to ensure that these groups are provided with safe and continuous health services and that socioeconomic support can be provided if necessary.
💡
Conclusion & Impact:It is essential to provide sustainable health services for the disadvantaged groups at risk with the health for all approach and the slogan “no one left behind”.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The COVID-19 pandemic once again reminded health inequalities. There are some groups that are more likely to develop the disease, as well as groups that are at risk of developing severe complications if they develop the disease, and have the potential to be negatively affected by the socioeconomic consequences of the pandemic. Postponing treatments for some diseases, such as cancer, can lead to clinically unwanted results. In addition to protecting patients at risk from COVID-19, it is the duty of the states to ensure that these groups are provided with safe and continuous health services and that socioeconomic support can be provided if necessary. It is essential to provide sustainable health services for the disadvantaged groups at risk with the health for all approach and the slogan “no one left behind”.

Özet

COVID-19 pandemisi sağlıkta eşitsizlikleri bir kez daha hatırlatmıştır. Hastalığa yakalanma olasılığı daha yüksek olan bazı grupların yanı sıra hastalığa yakalanması durumunda ağır komplikasyonlar geliştirme riski olan ve pandeminin sosyoekonomik sonuçları ile negatif yönde etkilenme potansiyeli olan gruplar vardır. Kanser gibi bazı hastalıkların tedavilerinin ertelenmesi klinik olarak kötü sonuçlara yol açabilir. Risk altındaki hastaları COVID-19’dan korumanın yanında, bu gruplara sağlık hizmetlerinin güvenli ve devamlı olarak sürdürülmesi, ayrıca gerektiğinde sosyoekonomik destek verilebilmesi devletlerin görevidir. Herkes için sağlık yaklaşımı ve “kimse arkada kalmamalı” sloganıyla risk altında olan ve dezavantajlı gruplar için sürdürülebilir sağlık hizmetlerinin sağlanması şarttır.

🔖

Cite This Article

ÖRÜN, H., TULUMTAŞ, Ö. S., AKIN, A. (2020). Some Matters to be Protected and Considered by Risk Groups From COVID-19 in the Context of Cancer Patients. Sağlık ve Toplum, Cilt: 30 - Sayı: 0, 98–102. https://ajindex.com/articles/305437

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Liang W, Guan W, Chen R, et al. Cancer patients in SARSCoV- 2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335–37
  2. You B, Ravaud A, Canivet A, et al. The official French guidelines to protect patients with cancer against SARSCoV- 2 infection. Lancet Oncol. 2020. doi: 10.1016/S1470- 2045(20)30204-7
  3. Coronavirus leads to chemotherapy cancellation. https:// www.braintumourresearch.org/media/news/news-item/ 2020/04/07/coronavirus-leads-to-chemotherapy-cancellation (Son Erişim Tarihi: 08.04.2020
  4. Should Cancer Treatment Be Continued During The Pandemic? A Case-By-Case Dıscussıon Is Requıred. https:// www.esmo.org/oncology-news/should-cancer-treatment- be-continued-during-the-pandemic-a-case-by-case- discussion-is-required (Son Erişim Tarihi: 08.04.2020
  5. Wang Z, Wang J, He J. Active and EffectiveMeasures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA Oncol. 2020. doi: 10.1001/jamaoncol. 2020.1198. Türk Hematoloji Derneği, Hematoloji Hastaları İçin COVID-19 İle İlgili Sorular Ve Cevaplar. http://www.thd. org.tr/thdData/userfiles/file/HEMATOLOJI%CC%87%20 HASTALARI%20I%CC%87C%CC%A7I%CC%87N%20 COVID%2019%20I%CC%87LE%20I%CC%87LGI%CC% 87LI%CC%87%20SORULAR%20VE%20CEVAPLAR% 20SON1304.pdf. Erişim tarihi: 18.05.2020. Türk Tıbbi Onkoloji Derneği, COVID-19 Pandemisi Danışma Kurulunun Kanser Hasta ve Hasta Yakınlarına Yönelik Öneriler. https://www.kanser.org/saglik/toplum/ turk-tibbi-onkoloji-dernegi-covid19-pandemisi-danisma-kurulunun- tibbi-onkologlara-yonelik-onerileri/2019. Erişim tarihi: 18.05.2020. “Kanserli Çocuklara Umut Vakfı “, “Nadir Hastalıklar Ağı”, “Bir Dileğim Var Derneği”nin bilgilerine başvurulmuştur.